| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -7.4e-06 | 1 |